Johann de Bono
Consultant at the Institute of Cancer Research
Professor Johann de Bono is Head of the Division of Clinical Studies and an international expert in the development of molecularly targeted cancer therapies against adult cancers. He runs one of the world’s largest phase I clinical trials units for cancer and has also led phase III trials of the prostate cancer drugs abiraterone and cabazitaxel.
See also: Institute of Cancer Research
Johann de Bono News
An effective immunotherapy for advanced prostate cancer
BBC - 28-Nov-2019
Only 5% saw their tumours shrink, but may be more successful if used earlierRead more...
New drug slowed tumour growth in men with prostate cancer
BBC - 30-Sep-2019
Olaparib delays cancer growth by months, which means the increased lifespanRead more...
Drug attacks cancers cells using trojan horse antibody
Independent - 08-Feb-2019
Novel mechanisms for attacking cancer cells are always good newsRead more...